{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T13:19:05Z","timestamp":1777987145658,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Studies looking into the concordance between late effects reported by physicians vs. those reported by Hodgkin lymphoma (HL) survivors are missing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A Life Situation Questionnaire focusing on late effects collected data from 1230 HL survivors (median follow-up 14.3\u00a0years). Twenty-six disease- and treatment-related late effects from various organ systems were matched with physician-recorded data. The concordance between physicians and survivors was systematically evaluated using percentage agreement and kappa statistics. Potential non-responder biases and associations with patient and disease characteristics were also investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Agreement levels (indicated by kappa statistics) varied from none to moderate agreement, with the highest Kappa values observed for myocardial infarction (kappa\u2009=\u20090.55, 95% CI 0.43\u20130.66) and pulmonary embolism (kappa\u2009=\u20090.55, 95% CI 0.35\u20130.75). HL survivors consistently reported a higher prevalence of late effects compared with physicians. Notably, the prevalence of subjective symptoms such as persistent fatigue and xerostomia was repeatedly underreported by physicians. A trend towards higher concordance was observed in survivors with higher clinical stage, higher education level, and treatment initiated at younger ages. Additionally, findings indicated that survivors who did not respond to the questionnaire experienced fewer late effects compared to those who did respond.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Substantial discrepancies were noted in the reported prevalence of late effects between survivors and physicians, especially for outcomes which are not easily quantified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Implications for Cancer Survivors<\/jats:title>\n                    <jats:p>It is therefore essential to integrate outcomes reported by both physicians and survivors to achieve a comprehensive assessment of the long-term consequences of HL treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11764-024-01694-0","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T11:03:02Z","timestamp":1729249382000},"page":"883-894","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Concordance between late effects reported by physicians and patients in a cohort of long-term Hodgkin lymphoma survivors: an analysis of data from nine consecutive EORTC-LYSA trials"],"prefix":"10.1007","volume":"20","author":[{"given":"Sidsel J.","family":"Juul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e1ra","family":"Rossetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berthe M. P.","family":"Aleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flora E.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marleen A. E.","family":"van der Kaaij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Giusti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Meijnders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M. M.","family":"Raemaekers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanneke C.","family":"Kluin-Nelemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Spina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daphne","family":"Krzisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Bigenwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aspasia","family":"Stamatoullas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter J.","family":"Plattel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Hutchings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja V.","family":"Maraldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,18]]},"reference":[{"issue":"7","key":"1694_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41408-021-00518-z","volume":"11","author":"R Mohty","year":"2021","unstructured":"Mohty R, Dulery R, Bazarbachi AH, Savani M, Hamed RA, Bazarbachi A, et al. Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapies. Blood Cancer J. 2021;11(7):1\u201310. https:\/\/doi.org\/10.1038\/s41408-021-00518-z.","journal-title":"Blood Cancer J"},{"issue":"8","key":"1694_CR2","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1200\/JCO.2014.57.9334","volume":"33","author":"M Di Maio","year":"2015","unstructured":"Di Maio M, Gallo C, Leighl NB, Piccirillo MC, Daniele G, Nuzzo F, et al. Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials. J Clin Oncol. 2015;33(8):910\u20135. https:\/\/doi.org\/10.1200\/JCO.2014.57.9334.","journal-title":"J Clin Oncol"},{"issue":"24","key":"1694_CR3","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1093\/jnci\/djr493","volume":"103","author":"E Basch","year":"2011","unstructured":"Basch E, Bennett A, Pietanza MC. Use of patient-reported outcomes to improve the predictive accuracy of clinician-reported adverse events. JNCI J Natl Cancer Inst. 2011;103(24):1808\u201310. https:\/\/doi.org\/10.1093\/jnci\/djr493.","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"17","key":"1694_CR4","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1200\/JCO.2004.03.025","volume":"22","author":"EK Fromme","year":"2004","unstructured":"Fromme EK, Eilers KM, Mori M, Hsieh YC, Beer TM. How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30. J Clin Oncol. 2004;22(17):3485\u201390. https:\/\/doi.org\/10.1200\/JCO.2004.03.025.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1694_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0885-3924(91)90518-9","volume":"6","author":"SA Grossman","year":"1991","unstructured":"Grossman SA, Sheidler VR, Swedeen K, Mucenski J, Piantadosi S. Correlation of patient and caregiver ratings of cancer pain. J Pain Symptom Manage. 1991;6(2):53\u20137. https:\/\/doi.org\/10.1016\/0885-3924(91)90518-9.","journal-title":"J Pain Symptom Manage"},{"issue":"3 Suppl 2","key":"1694_CR6","first-page":"4","volume":"34","author":"NJ Vogelzang","year":"1997","unstructured":"Vogelzang NJ, Breitbart W, Cella D, Curt GA, Groopman JE, Horning SJ, et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The fatigue coalition. Semin Hematol. 1997;34(3 Suppl 2):4\u201312.","journal-title":"Semin Hematol"},{"issue":"3","key":"1694_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0885-3924(01)00264-0","volume":"21","author":"AS Str\u00f6mgren","year":"2001","unstructured":"Str\u00f6mgren AS, Groenvold M, Pedersen L, Olsen AK, Spile M, Sj\u00f8gren P. Does the medical record cover the symptoms experienced by cancer patients receiving palliative care? A comparison of the record and patient self-rating. J Pain Symptom Manag. 2001;21(3):189\u201396. https:\/\/doi.org\/10.1016\/S0885-3924(01)00264-0.","journal-title":"J Pain Symptom Manag"},{"issue":"3","key":"1694_CR8","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jpainsymman.2011.09.017","volume":"44","author":"A Sikorskii","year":"2012","unstructured":"Sikorskii A, Wyatt G, Tamkus D, Victorson D, Rahbar MH, Ahn S. Concordance between patient reports of cancer-related symptoms and medical records documentation. J Pain Symptom Manag. 2012;44(3):362. https:\/\/doi.org\/10.1016\/j.jpainsymman.2011.09.017.","journal-title":"J Pain Symptom Manag"},{"issue":"8","key":"1694_CR9","first-page":"530","volume":"14","author":"S Pakhomov","year":"2008","unstructured":"Pakhomov S, Jacobsen SJ, Chute CG, Roger VL. Agreement between patient-reported symptoms and their documentation in the medical record. Am J Manag Care. 2008;14(8):530\u20139.","journal-title":"Am J Manag Care"},{"issue":"5","key":"1694_CR10","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/0014-2964(79)90138-5","volume":"15","author":"M Tubiana","year":"1979","unstructured":"Tubiana M, Henry-Amar M, Hayat M, Breur K, van der Werf-Messing B, Burgers M. Long-term results of the E.O.R.T.C. randomized study of irradiation and vinblastine in clinical stages I and II of Hodgkin\u2019s disease. Eur J Cancer. 1979;15(5):645\u201357. https:\/\/doi.org\/10.1016\/0014-2964(79)90138-5.","journal-title":"Eur J Cancer"},{"issue":"3","key":"1694_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0014-2964(81)90128-6","volume":"17","author":"M Tubiana","year":"1981","unstructured":"Tubiana M, Hayat M, Henry-Amar M, Breur K, van der Werf Messing B, Burgers M. Five-year results of the E.O.R.T.C. randomized study of splenectomy and spleen irradiation in clinical stages I and II of Hodgkin\u2019s disease. Eur J Cancer. 1981;17(3):355\u201363. https:\/\/doi.org\/10.1016\/0014-2964(81)90128-6.","journal-title":"Eur J Cancer"},{"issue":"2","key":"1694_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1200\/JCO.1988.6.2.239","volume":"6","author":"P Carde","year":"1988","unstructured":"Carde P, Burgers JM, Henry-Amar M, Hayat M, Sizoo W, Van der Schueren E, et al. Clinical stages I and II Hodgkin\u2019s disease: a specifically tailored therapy according to prognostic factors. J Clin Oncol Off J Am Soc Clin Oncol. 1988;6(2):239\u201352. https:\/\/doi.org\/10.1200\/JCO.1988.6.2.239.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"11","key":"1694_CR13","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1200\/JCO.1993.11.11.2258","volume":"11","author":"P Carde","year":"1993","unstructured":"Carde P, Hagenbeek A, Hayat M, Monconduit M, Thomas J, Burgers MJ, et al. Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin\u2019s disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group. J Clin Oncol Off J Am Soc Clin Oncol. 1993;11(11):2258\u201372. https:\/\/doi.org\/10.1200\/JCO.1993.11.11.2258.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"1694_CR14","doi-asserted-by":"publisher","unstructured":"Somers R, Carde P, Tarayre M, Thomas J, Hagenbeek A, Monconduit M, et al. A randomized study in stage IIIB and IV Hodgkin\u2019s disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie cont. Henry-amar M, editor. J ClinOncol. 1994;12-279. https:\/\/doi.org\/10.1200\/JCO.1994.12.2.279.","DOI":"10.1200\/JCO.1994.12.2.279"},{"issue":"24","key":"1694_CR15","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1056\/NEJMoa022628","volume":"348","author":"BMP Aleman","year":"2003","unstructured":"Aleman BMP, Raemaekers JMM, Tirelli U, Bortolus R, van\u2019t Veer MB, Lybeert MLM, et al. Involved-field radiotherapy for advanced Hodgkin\u2019s lymphoma. N Engl J Med. 2003;348(24):2396\u2013406. https:\/\/doi.org\/10.1056\/NEJMoa022628.","journal-title":"N Engl J Med"},{"issue":"19","key":"1694_CR16","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1200\/JCO.2005.05.2746","volume":"24","author":"EM Noordijk","year":"2006","unstructured":"Noordijk EM, Carde P, Dupouy N, Hagenbeek A, Krol ADG, Kluin-Nelemans JC, et al. Combined-modality therapy for clinical stage I or II Hodgkin\u2019s lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials. J Clin Oncol Off J Am Soc Clin Oncol. 2006;24(19):3128\u201335. https:\/\/doi.org\/10.1200\/JCO.2005.05.2746.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"19","key":"1694_CR17","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1056\/NEJMoa064601","volume":"357","author":"C Ferm\u00e9","year":"2007","unstructured":"Ferm\u00e9 C, Eghbali H, Meerwaldt JH, Rieux C, Bosq J, Berger F, et al. Chemotherapy plus involved-field radiation in early-stage Hodgkin\u2019s disease. N Engl J Med. 2007;357(19):1916\u201327. https:\/\/doi.org\/10.1056\/NEJMoa064601.","journal-title":"N Engl J Med"},{"key":"1694_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejca.2017.05.005","volume":"81","author":"C Ferm\u00e9","year":"2017","unstructured":"Ferm\u00e9 C, Thomas J, Brice P, Casasnovas O, Vranovsky A, Bologna S, et al. ABVD or BEACOPP baseline along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: results of the European Organisation for Research and Treatment of Cancer (EORTC)\u2013Groupe d\u2019\u00c9tude des Lymphomes de l\u2019Adulte (GELA) H9-U intergroup randomised trial. Eur J Cancer. 2017;81:45\u201355. https:\/\/doi.org\/10.1016\/j.ejca.2017.05.005.","journal-title":"Eur J Cancer"},{"issue":"5","key":"1694_CR19","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.ijrobp.2017.10.015","volume":"100","author":"J Thomas","year":"2018","unstructured":"Thomas J, Ferm\u00e9 C, Noordijk EM, Morschhauser F, Girinsky T, Gaillard I, et al. Comparison of 36 Gy, 20 Gy, or no radiation therapy after 6 cycles of EBVP chemotherapy and complete remission in early-stage Hodgkin lymphoma without risk factors: results of the EORT-GELA H9-F Intergroup randomized trial. Int J Radiat Oncol. 2018;100(5):1133\u201345. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.10.015.","journal-title":"Int J Radiat Oncol"},{"issue":"1","key":"1694_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S1359-6349(12)70019-8","volume":"10","author":"P Meijnders","year":"2012","unstructured":"Meijnders P, Carde P, Girinsky T, Kluin-Nelemans JC, Henry-Amar M, Raemaekers JMM, et al. Clinical achievements of the EORTC Lymphoma Group and aspects of future group strategy. Eur J Cancer Suppl. 2012;10(1):105\u201311. https:\/\/doi.org\/10.1016\/S1359-6349(12)70019-8.","journal-title":"Eur J Cancer Suppl"},{"issue":"6","key":"1694_CR21","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/0895-4356(90)90158-L","volume":"43","author":"AR Feinstein","year":"1990","unstructured":"Feinstein AR, Cicchetti DV. High agreement but low kappa: I. The problems of two paradoxes. J Clin Epidemiol. 1990;43(6):543\u20139. https:\/\/doi.org\/10.1016\/0895-4356(90)90158-L.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"1694_CR22","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/0895-4356(90)90159-M","volume":"43","author":"DV Cicchetti","year":"1990","unstructured":"Cicchetti DV, Feinstein AR. High agreement but low kappa: II. Resolving the paradoxes. J Clin Epidemiol. 1990;43(6):551\u20138. https:\/\/doi.org\/10.1016\/0895-4356(90)90159-M.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"1694_CR23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2307\/2529786","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics. 1977;33(2):363\u201374. https:\/\/doi.org\/10.2307\/2529786.","journal-title":"Biometrics"},{"issue":"5","key":"1694_CR24","first-page":"360","volume":"37","author":"AJ Viera","year":"2005","unstructured":"Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37(5):360\u20133.","journal-title":"Fam Med"},{"issue":"5","key":"1694_CR25","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s00520-005-0009-2","volume":"14","author":"J Homsi","year":"2006","unstructured":"Homsi J, Walsh D, Rivera N, Rybicki LA, Nelson KA, LeGrand SB, et al. Symptom evaluation in palliative medicine: patient report vs systematic assessment. Support Care Cancer. 2006;14(5):444\u201353. https:\/\/doi.org\/10.1007\/s00520-005-0009-2.","journal-title":"Support Care Cancer"},{"issue":"8","key":"1694_CR26","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.ejca.2006.01.032","volume":"42","author":"MA Petersen","year":"2006","unstructured":"Petersen MA, Larsen H, Pedersen L, Sonne N, Groenvold M. Assessing health-related quality of life in palliative care: comparing patient and physician assessments. Eur J Cancer. 2006;42(8):1159\u201366. https:\/\/doi.org\/10.1016\/j.ejca.2006.01.032.","journal-title":"Eur J Cancer"},{"issue":"8","key":"1694_CR27","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1640::AID-CNCR21>3.0.CO;2-#","volume":"83","author":"S Newell","year":"1998","unstructured":"Newell S, Sanson-Fisher RW, Girgis A, Bonaventura A. How well do Medical oncologists\u2019 perceptions reflect their patients\u2019 reported physical and psychosocial problems? Cancer. 1998;83(8):1640\u201351.","journal-title":"Cancer"},{"issue":"4","key":"1694_CR28","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1200\/JCO.1998.16.4.1594","volume":"16","author":"SD Passik","year":"1998","unstructured":"Passik SD, Dugan W, McDonald MV, Rosenfeld B, Theobald DE, Edgerton S. Oncologists\u2019 recognition of depression in their patients with cancer. J Clin Oncol. 1998;16(4):1594\u2013600. https:\/\/doi.org\/10.1200\/JCO.1998.16.4.1594.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1694_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1365-2354.2005.00482.x","volume":"14","author":"H Ryan","year":"2005","unstructured":"Ryan H, Schofield P, Cockburn J, Butow P, Tattersall M, Turner J, et al. How to recognize and manage psychological distress in cancer patients. Eur J Cancer Care (Engl). 2005;14(1):7\u201315. https:\/\/doi.org\/10.1111\/j.1365-2354.2005.00482.x.","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"6b","key":"1694_CR30","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1667\/RR1903.1","volume":"174","author":"GT Armstrong","year":"2010","unstructured":"Armstrong GT, Stovall M, Robison LL. Long-term effects of radiation exposure among adult survivors of childhood cancer: results from the childhood cancer survivor study. Radiat Res. 2010;174(6b):840\u201350. https:\/\/doi.org\/10.1667\/RR1903.1.","journal-title":"Radiat Res"},{"key":"1694_CR31","doi-asserted-by":"publisher","unstructured":"Fares CM, Williamson TJ, Theisen MK, Cummings A, Bornazyan K, Carroll J, et al. Low Concordance of patient-reported outcomes with clinical and clinical trial documentation. JCO Clin Cancer Inform. 2018;2:CCI.18.00059. https:\/\/doi.org\/10.1200\/CCI.18.00059.","DOI":"10.1200\/CCI.18.00059"},{"issue":"11","key":"1694_CR32","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S1470-2045(06)70910-X","volume":"7","author":"E Basch","year":"2006","unstructured":"Basch E, Iasonos A, McDonough T, Barz A, Culkin A, Kris MG, et al. Patient versus clinician symptom reporting using the national cancer institute common terminology criteria for adverse events: results of a questionnaire-based study. Lancet Oncol. 2006;7(11):903\u20139. https:\/\/doi.org\/10.1016\/S1470-2045(06)70910-X.","journal-title":"Lancet Oncol"},{"issue":"9","key":"1694_CR33","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.ajic.2015.04.208","volume":"43","author":"JF Echaiz","year":"2015","unstructured":"Echaiz JF, Cass C, Henderson JP, Babcock HM, Marschall J. Low correlation between self-report and medical record documentation of urinary tract infection symptoms. Am J Infect Control. 2015;43(9):983\u20136. https:\/\/doi.org\/10.1016\/j.ajic.2015.04.208.","journal-title":"Am J Infect Control"},{"issue":"12","key":"1694_CR34","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/bjc.1997.610","volume":"76","author":"G Macquart-Moulin","year":"1997","unstructured":"Macquart-Moulin G, Viens P, Bouscary ML, Genre D, Resbeut M, Gravis G, et al. Discordance between physicians\u2019 estimations and breast cancer patients\u2019 self-assessment of side-effects of chemotherapy: an issue for quality of care. Br J Cancer. 1997;76(12):1640\u20135. https:\/\/doi.org\/10.1038\/bjc.1997.610.","journal-title":"Br J Cancer"},{"issue":"2","key":"1694_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4104\/pcrj.2011.00098","volume":"21","author":"AM Barbara","year":"2012","unstructured":"Barbara AM, Loeb M, Dolovich L, Brazil K, Russell M. Agreement between self-report and medical records on signs and symptoms of respiratory illness. Prim Care Respir J J Gen Pract Airw Group. 2012;21(2):145\u201352. https:\/\/doi.org\/10.4104\/pcrj.2011.00098.","journal-title":"Prim Care Respir J J Gen Pract Airw Group"},{"issue":"8","key":"1694_CR36","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1007\/s00520-016-3297-9","volume":"24","author":"TM Atkinson","year":"2016","unstructured":"Atkinson TM, Ryan SJ, Bennett AV, Stover AM, Saracino RM, Rogak LJ, et al. The Association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2016;24(8):3669\u201376. https:\/\/doi.org\/10.1007\/s00520-016-3297-9.","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"issue":"14","key":"1694_CR37","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1200\/JCO.2008.21.1813","volume":"27","author":"WM Leisenring","year":"2009","unstructured":"Leisenring WM, Mertens AC, Armstrong GT, Stovall MA, Neglia JP, Lanctot JQ, et al. Pediatric cancer survivorship research: experience of the childhood cancer survivor study. J Clin Oncol. 2009;27(14):2319\u201327. https:\/\/doi.org\/10.1200\/JCO.2008.21.1813.","journal-title":"J Clin Oncol"},{"issue":"11","key":"1694_CR38","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/sj.bmt.1702419","volume":"25","author":"AD Louie","year":"2000","unstructured":"Louie AD, Robison LL, Bogue M, Hyde S, Forman SJ, Bhatia S. Validation of self-reported complications by bone marrow transplantation survivors. Bone Marrow Transplant. 2000;25(11):1191\u20136. https:\/\/doi.org\/10.1038\/sj.bmt.1702419.","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"1694_CR39","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1136\/jech.2005.039131","volume":"60","author":"C Navarro","year":"2006","unstructured":"Navarro C, Chirlaque MD, Tormo MJ, P\u00e9rez-Flores D, Rodr\u00edguez-Barranco M, S\u00e1nchez-Villegas A, et al. Validity of self reported diagnoses of cancer in a major Spanish prospective cohort study. J Epidemiol Community Health. 2006;60(7):593\u20139. https:\/\/doi.org\/10.1136\/jech.2005.039131.","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"1694_CR40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.12758\/mda.2021.08","volume":"16","author":"R Becker","year":"2022","unstructured":"Becker R. Gender and survey participation: an event history analysis of the gender effects of survey participation in a probability-based multi-wave panel study with a sequential mixed-mode design. Methods Data Anal. 2022;16(1):30. https:\/\/doi.org\/10.12758\/mda.2021.08.","journal-title":"Methods Data Anal"},{"issue":"1","key":"1694_CR41","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12875-016-0440-0","volume":"17","author":"AE Thompson","year":"2016","unstructured":"Thompson AE, Anisimowicz Y, Miedema B, Hogg W, Wodchis WP, Aubrey-Bassler K. The influence of gender and other patient characteristics on health care-seeking behaviour: a QUALICOPC study. BMC Fam Pract. 2016;17(1):38. https:\/\/doi.org\/10.1186\/s12875-016-0440-0.","journal-title":"BMC Fam Pract"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-024-01694-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-024-01694-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-024-01694-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:24:56Z","timestamp":1777983896000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11764-024-01694-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1694"],"URL":"https:\/\/doi.org\/10.1007\/s11764-024-01694-0","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,18]]},"assertion":[{"value":"26 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable (this study is exclusively register-based and all data are anonymized).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}